Published in Lancet on May 28, 1994
Gaining power and precision by using model-based weights in the analysis of late stage cancer trials with substantial treatment switching. Stat Med (2015) 0.75
External data required timely response by the Trial Steering-Data Monitoring Committee for the NALoxone InVEstigation (N-ALIVE) pilot trial. Contemp Clin Trials Commun (2017) 0.75
Statistical guidelines for contributors to medical journals. Br Med J (Clin Res Ed) (1983) 10.90
Mortality from overdose among injecting drug users recently released from prison: database linkage study. BMJ (1998) 5.05
Multicentre trial on feeding low birthweight infants: effects of diet on early growth. Arch Dis Child (1984) 4.62
No escape: HIV transmission in jail. BMJ (1993) 3.91
Escape from collective denial: HIV transmission during surgery. BMJ (1991) 3.79
Is dialysis hypotension caused by an abnormality of venous tone? Br Med J (Clin Res Ed) (1988) 3.48
Early diet in preterm babies and developmental status at 18 months. Lancet (1990) 3.34
Anonymous HIV surveillance in Saughton Prison, Edinburgh. AIDS (1992) 3.29
Long-term survival of patients with breast cancer: a study of the curability of the disease. Br Med J (1979) 3.29
Revised guidelines for HIV infected health care workers. BMJ (1993) 3.16
Misuse of statistical methods: critical assessment of articles in BMJ from January to March 1976. Br Med J (1977) 3.08
Early diet in preterm babies and developmental status in infancy. Arch Dis Child (1989) 2.79
Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: any connection? BMJ (1995) 2.74
Drug injection and HIV prevalence in inmates of Glenochil prison. BMJ (1995) 2.66
Study of infection with HIV and related risk factors in young offenders' institution. BMJ (1993) 2.58
Inside methodology: HIV surveillance in prisons. AIDS (1994) 2.39
Quality of life measures in health care. III: Resource allocation. BMJ (1992) 2.31
Conclusions of the corneal transplant follow up study. Collaborating Surgeons. Br J Ophthalmol (1997) 2.23
High energy neutron treatment for pelvic cancers: study stopped because of increased mortality. BMJ (1991) 2.12
Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus-induced B-cell lines. Nature (1981) 2.10
Prospective study of cancer in patients with hypogammaglobulinaemia. Lancet (1985) 2.03
Uptake of confidential, named HIV testing in Scottish prisons. Lancet (1992) 2.01
Prisoners' uptake of confidential, named HIV testing. Lancet (1992) 1.99
Bovine Creutzfeldt-Jakob disease? BMJ (1996) 1.97
Prevalence of hepatitis C virus infection among injecting drug users in Glasgow 1990-1996: are current harm reduction strategies working? J Infect (2000) 1.94
A new approach to the study of human B lymphocyte function using an indirect plaque assay and a direct B cell activator. Immunol Rev (1979) 1.91
Association of HLA types A1-B8-DR3 and B27 with rapid and slow progression of HIV disease. QJM (1996) 1.88
Reproducibility of measurements of oestrogen-receptor concentration in breast cancer. Br J Cancer (1977) 1.85
Fatal uncertainty: death-rate from use of ecstasy or heroin. Lancet (1999) 1.83
A randomised multicentre study of human milk versus formula and later development in preterm infants. Arch Dis Child Fetal Neonatal Ed (1994) 1.70
Corneal graft survival and visual outcome. A multicenter Study. Corneal Transplant Follow-up Study Collaborators. Ophthalmology (1994) 1.69
Clinical characteristics of akathisia. A systematic investigation of acute psychiatric inpatient admissions. Br J Psychiatry (1983) 1.64
Antibodies to neutrophil cytoplasmic antigen in systemic vasculitis. Lancet (1987) 1.61
Anonymous HIV surveillance with risk factor elicitation at Scotland's largest prison, Barlinnie. AIDS (1995) 1.61
Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: sequencing, timing, and outcome. J Clin Oncol (1991) 1.59
A live human B-cell activator operating in isolation of other cellular influences. Scand J Immunol (1979) 1.54
No evidence for decreased lymphocyte reactivity in Crohn's disease. Gastroenterology (1974) 1.49
Anonymous HIV surveillance with risk-factor elicitation: at Perth (for men) and Cornton Vale (for women) prisons in Scotland. Int J STD AIDS (1997) 1.48
Prevalence of hepatitis C in prisons: WASH-C surveillance linked to self-reported risk behaviours. QJM (1999) 1.47
Long term survival analysis: the curability of breast cancer. Stat Med (1983) 1.44
Characteristics of Epstein-Barr virus activation of human B lymphocytes. J Exp Med (1981) 1.43
Assessing clinical trials--trial discipline. Br Med J (Clin Res Ed) (1981) 1.42
Efficacy of rice-based oral rehydration. Lancet (1996) 1.40
Recent non-sterile inoculation injuries to dental professionals in the Lothian region of Scotland. Br Dent J (1994) 1.39
Pokeweed mitogen induced differentiation of human B cells: evaluation by a protein A haemolytic plaque assay. Immunology (1979) 1.39
Use of plaque assays to study thyroglobulin autoantibody synthesis by human peripheral blood lymphocytes. Scand J Immunol (1981) 1.39
Increased expression of the CD45RO (memory) antigen on T cells in HIV-infected children. AIDS (1991) 1.37
Organ donation in a neurosurgical unit. BMJ (1991) 1.34
Influence of donor and histocompatibility factors on corneal graft outcome. Transplantation (1994) 1.31
Observer variation in the clinical assessment of stroke. Age Ageing (1976) 1.31
The separation of human serum IgG into subclass fractions by immunoaffinity chromatography and assessment of specific antibody activity. J Immunol Methods (1984) 1.21
X-Linked agammaglobulinemia patients are not infected with Epstein-Barr virus: implications for the biology of the virus. J Virol (1999) 1.15
Corneal transplantation in the United Kingdom and Republic of Ireland. Br J Ophthalmol (1993) 1.15
Conservation and accessibility of an inner core lipopolysaccharide epitope of Neisseria meningitidis. Infect Immun (1999) 1.15
Rice-based oral rehydration solution for treating diarrhoea. Cochrane Database Syst Rev (2000) 1.15
Progression of HIV: follow-up of Edinburgh injecting drug users with narrow seroconversion intervals in 1983-1985. AIDS (1996) 1.11
Second anonymous HIV surveillance in Saughton Prison, Edinburgh: prisoners give a lead to other heterosexuals on being HIV tested. AIDS (1993) 1.10
The consumer principle of randomisation. Lancet (1994) 1.07
Clinical and surgical factors influencing corneal graft survival, visual acuity, and astigmatism. Corneal Transplant Follow-up Study Collaborators. Ophthalmology (1996) 1.07
Humoral and cellular immunity in humans studied at the cell level from birth to two years of age. Immunol Rev (1981) 1.05
Drugs in British prisons. Policies need outside scrutiny if they are to do more good than harm. BMJ (1998) 1.05
Atenolol eye drops in glaucoma: a double-masked, controlled study. Br J Ophthalmol (1977) 1.04
Antibodies directed against neutrophils (C-ANCA and P-ANCA) are of distinct diagnostic value in systemic vasculitis. Q J Med (1990) 1.04
Myocardial dysfunction in patients infected with HIV: prevalence and risk factors. Br Heart J (1992) 1.02
Atenolol eye drops. Br Med J (1976) 1.00
Tardive dyskinesia: a 3-year follow-up study. Psychol Med (1983) 1.00
Hepatitis B outbreak at Glenochil prison during January to June 1993. Epidemiol Infect (1998) 1.00
Injecting drug users in Edinburgh have a high rate of recidivism. Addiction (2000) 0.99
Mitogen-induced differentiation of human CLL lymphocytes to antibody-secreting cells. Scand J Immunol (1979) 0.99
Fatal pneumococcal meningitis in an HIV-infected drug user despite previous pneumococcal immunization. Int J STD AIDS (1994) 0.99
HIV prevalence and risk factors in university students. AIDS (1995) 0.98
Osteosclerotic myeloma variants. Skeletal Radiol (1988) 0.98
Nonrandom chromosomal aberrations in chronic lymphocytic leukemia revealed by polyclonal B-cell-mitogen stimulation. Blood (1980) 0.97
Assessing clinical trials--first steps. Br Med J (Clin Res Ed) (1981) 0.97
Acquired immune deficiency syndrome predictions for England and Wales (1992-97): sensitivity analysis, information, decision. J R Stat Soc Ser A Stat Soc (1995) 0.97
Assessing, clinical trials-- protocol and monitoring. Br Med J (Clin Res Ed) (1981) 0.96
Subclass distribution of IgG autoantibodies in bullous pemphigoid. J Invest Dermatol (1986) 0.96
Method used to identify previously undiagnosed infections in the HIV outbreak at Glenochil prison. Epidemiol Infect (1999) 0.96
Cytotoxic T lymphocyte activity and CD8 subpopulations in children at risk of HIV infection. Clin Exp Immunol (1994) 0.95
Ocular hypotensive effect of late pregnancy with and without high blood pressure. Br J Ophthalmol (1985) 0.95
Completing the molecular investigation into the HIV outbreak at Glenochil prison. Epidemiol Infect (1999) 0.95
Substantial benefits of tissue matching in renal transplantation. Transplantation (1987) 0.94
Transmission of HIV in prison. BMJ (1993) 0.93
Pre-AIDS mortality in the Edinburgh City Hospital HIV cohort. Stat Med (1997) 0.92
Negative effect of HLA-DR matching on corneal transplant rejection. Transplant Proc (1995) 0.92
Human cytomegalovirus infection is not increased in common variable immunodeficiency. J Clin Immunol (1996) 0.92
CD4 and CD8 lymphocytes in diagnosis and disease progression of pediatric HIV infection. Pediatr AIDS HIV Infect (1996) 0.91
Prison rights: mandatory drugs tests and performance indicators for prisons. BMJ (1996) 0.91